Your browser doesn't support javascript.
loading
Once-a-week tigecycline for the treatment of drug-resistant TB.
Deshpande, Devyani; Magombedze, Gesham; Srivastava, Shashikant; Bendet, Paula; Lee, Pooi S; Cirrincione, Kayle N; Martin, Katherine R; Dheda, Keertan; Gumbo, Tawanda.
Afiliação
  • Deshpande D; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Magombedze G; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Srivastava S; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Bendet P; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Lee PS; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Cirrincione KN; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Martin KR; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Dheda K; Lung Infection and Immunity Unit, Department of Medicine, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Gumbo T; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
J Antimicrob Chemother ; 74(6): 1607-1617, 2019 06 01.
Article em En | MEDLINE | ID: mdl-30820554
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tigeciclina / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tigeciclina / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos